Daily Data Flow

S&P 500 Rises on Pharmaceutical Deal Despite Disappointing Data

S&P 500 Rises Despite Disappointing Data (Bloomberg)

New York-area manufacturing data did not live up to forecasts, but a $25 billion deal by pharmaceutical company Actavis Plc to buy Forest Laboratories buoyed the market. The S&P 500 rose 0.1%, to within eight points of its record close. “Weaker economic numbers have been shrugged off,” Eric Green, director of research and fund manager at Philadelphia-based Penn Capital Management, said. “It seems like the consensus view is that weather is a huge issue in the numbers. The outlook looks pretty benign right now. We can probably reach new highs in the near term in the equity markets.”

Sign Up


Comment with Facebook